The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keler, T.
Right arrow Articles by Deo, Y. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keler, T.
Right arrow Articles by Deo, Y. M.
The Journal of Immunology, 2000, 164: 5746-5752.
Copyright © 2000 by The American Association of Immunologists

Differential Effect of Cytokine Treatment on Fc{alpha} Receptor I- and Fc{gamma} Receptor I-Mediated Tumor Cytotoxicity by Monocyte-Derived Macrophages

Tibor Keler1,*, Paul K. Wallace{dagger}, Laura A. Vitale*, Christina Russoniello*, Karuna Sundarapandiyan*, Robert F. Graziano* and Yashwant M. Deo*

* Medarex, Inc., Annandale, NJ 08801; and {dagger} Department of Microbiology, Dartmouth Medical School, Lebanon, NH 03756

Macrophages represent an important effector cell for Ab-mediated tumor therapy. Previous studies have documented that cytokines can influence Fc receptor (FcR) expression and function. In this study we examined the tumoricidal activities of the type I receptors for IgG (Fc{gamma}RI) and the IgA FcR (Fc{alpha}RI) on monocyte-derived macrophages (MDM) cultured in the presence of IFN-{gamma}, M-CSF, or GM-CSF. Bispecific Abs were used to target a Her2/neu breast carcinoma cell line, SKBR-3, to Fc{alpha}RI or Fc{gamma}RI on MDM. Although Fc{alpha}RI and Fc{gamma}RI share a common signaling pathway contingent on association with the {gamma}-chain (FcR{gamma} subunit), a marked difference in their efficiency in mediating tumoricidal functions was seen in response to specific cytokines. M-CSF- and GM-CSF-treated MDM mediated efficient phagocytosis of SKBR-3 cells by Fc{alpha}RI and Fc{gamma}RI; however, IFN-{gamma}-treated MDM phagocytosed tumor cells only with the Fc{gamma}RI-directed bispecific Abs. Similarly, IFN-{gamma}-cultured MDM lysed tumor cells more efficiently via Fc{gamma}RI then by Fc{alpha}RI as measured in Ab-dependent cellular cytotoxicity assays. Conversely, GM-CSF-treated MDM mediated more efficient lysis of tumor cells via Fc{alpha}RI than Fc{gamma}RI, while M-CSF-cultured MDM were relatively less efficient in mediating Ab-dependent cellular cytotoxicity through either receptor. With the exception of IFN-{gamma}-mediated enhancement of Fc{gamma}RI expression and Fc{gamma}RI {gamma}-chain complexes, the regulation of Fc{gamma}RI- or Fc{alpha}RI-mediated activity occurred without significant change in either receptor expression or total complexes with {gamma} subunit. These data suggest that the efficiency of Ab-mediated tumor therapy, which depends on FcR effector cell functions, may be modified by the use of specific cytokines.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. N. Karagiannis, M. G. Bracher, J. Hunt, N. McCloskey, R. L. Beavil, A. J. Beavil, D. J. Fear, R. G. Thompson, N. East, F. Burke, et al.
IgE-Antibody-Dependent Immunotherapy of Solid Tumors: Cytotoxic and Phagocytic Mechanisms of Eradication of Ovarian Cancer Cells
J. Immunol., September 1, 2007; 179(5): 2832 - 2843.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. N. Forthal, G. Landucci, K. S. Cole, M. Marthas, J. C. Becerra, and K. Van Rompay
Rhesus macaque polyclonal and monoclonal antibodies inhibit simian immunodeficiency virus in the presence of human or autologous rhesus effector cells.
J. Virol., September 1, 2006; 80(18): 9217 - 9225.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
I. O. Gordon and R. S. Freedman
Defective Antitumor Function of Monocyte-Derived Macrophages from Epithelial Ovarian Cancer Patients
Clin. Cancer Res., March 1, 2006; 12(5): 1515 - 1524.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Otten, E. Rudolph, M. Dechant, C. W. Tuk, R. M. Reijmers, R. H. J. Beelen, J. G. J. van de Winkel, and M. van Egmond
Immature Neutrophils Mediate Tumor Cell Killing via IgA but Not IgG Fc Receptors
J. Immunol., May 1, 2005; 174(9): 5472 - 5480.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
R. Reljic, C. Crawford, S. Challacombe, and J. Ivanyi
Mouse IgA inhibits cell growth by stimulating tumor necrosis factor-{alpha} production and apoptosis of macrophage cell lines
Int. Immunol., April 1, 2004; 16(4): 607 - 614.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. P. Kumar, F. J. Piedrafita, and W. F. Reynolds
Peroxisome Proliferator-activated Receptor {gamma} Ligands Regulate Myeloperoxidase Expression in Macrophages by an Estrogen-dependent Mechanism Involving the -463GA Promoter Polymorphism
J. Biol. Chem., February 27, 2004; 279(9): 8300 - 8315.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. A. Guyre, T. Keler, S. L. Swink, L. A. Vitale, R. F. Graziano, and M. W. Fanger
Receptor Modulation by Fc{gamma}RI-Specific Fusion Proteins Is Dependent on Receptor Number and Modified by IgG
J. Immunol., December 1, 2001; 167(11): 6303 - 6311.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Komuro, N. Keicho, A. Iwamoto, and K. S. Akagawa
Human Alveolar Macrophages and Granulocyte-macrophage Colony-stimulating Factor-induced Monocyte-derived Macrophages Are Resistant to H2O2 via Their High Basal and Inducible Levels of Catalase Activity
J. Biol. Chem., June 22, 2001; 276(26): 24360 - 24364.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.